Dr Nghiem's areas of clinical interest are:

Dr Nghiem sees patients Tuesday mornings at the Seattle Cancer Care Alliance. For patient care issues please call: 206-288-1024.

Merkel cell carcinoma

  1. Nghiem P, McKee P, Haynes H. "Merkel Cell (Cutaneous Neuroendocrine) Carcinoma", Chapter in: Skin Cancer volume of the Atlas of Clinical Oncology, American Cancer Society, BC Decker Inc, Hamilton Ontario, 2001, Pages 127-141. [pdf]

  2. Herbst A, Haynes H, Nghiem P. Adjuvant Radiation and Lymph Node Surgery Should be the Standard of Care for Merkel Cell Carcinoma. J. Am Acad Dermatol. 2002. 46:640-642. [pdf]

  3. Longo MI, Nghiem P. Merkel Cell Carcinoma Treatment with Radiation: A Good Case Despite No Prospective Studies. Arch Dermatol. 2003. 139(12):1641-3. [pdf]
  1. Gupta SG, Wang LC, Penas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel Lymph Node Biopsy for Evaluation and Treatment of Patients with Merkel Cell Carcinoma: The Dana-Farber Experience and Meta-Analysis of the Literature. Arch Dermatol. 2006. 142(6):685-90. [pdf]
  1. Heath M, Nghiem P. Merkel Cell Carcinoma: If No Breslow, Then What? J Surg Oncol. 2007. 95(8):614-615. [pdf]

  2. Garneski K, Nghiem P. Merkel Cell Carcinoma Adjuvant Therapy: Current Data Support Radiation but Not Chemotherpay. J Am Acad Dermatol. 2007. 57(1):166-9. [pdf]

  3. Jaimes N, Nghiem P. Chapter 120: Merkel Cell Carcinoma. In Wolff K, Katz S, Goldsmith L, Gilcrhrest B, Leffell D, Paller A (Eds), Fitzpatrick's Dermatology in General Medicine. Mosby, 2007. [pdf]

  4. Lemos B, Nghiem P. Merkel Cell Carcinoma: More Deaths but Still no Pathway to Blame. J Invest Dermatol. 2007. 127(9):2100-2103. [pdf]

  5. Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Peñas PF, Nghiem P: Clinical Characteristics of Merkel Cell Carcinoma at Diagnosis in 195 Patients: the AEIOU Features. J Am Acad Dermatol. 2008. 58(3):375-81. [pdf]

 

[back to top]

Melanoma / cutaneous oncology

  1. Nghiem P, Kupper TS. "Basal- and Squamous-Cell Carcinomas". Chapter in: Principles of Molecular Medicine. Ed: L. Jameson, Humana Press, Totowa, NJ. 1998; Pages 785-788.

  2. Pathak M, Nghiem P, Fitzpatrick TB. "Acute and Chronic Effects of the Sun." Chapter in: Fitzpatrick's Dermatology in General Medicine, 5th Edn. Ed: I.M. Freedberg, et al, McGraw-Hill, 1999; pages 1598-1607.

  3. Pathak M, Fitzpatrick TB, Nghiem P, Aghassi DS. "Sun-Protective Agents: Formulations, Effects, and Side Effects". Chapter in: Fitzpatrick's Dermatology in General Medicine, 5th Edn. Ed: I.M. Freedberg, et al, McGraw-Hill, 1999; pages 2742-2763.

  4. Molina M, Molina L, Fitzpatrick TB and Nghiem P. "Ozone Depletion and Human Health Effects" Chapter in: Environmental Medicine Ed: Lennart Moller, Karolinska Institute, Stockholm, Sweden, 2000, Pages 28-51.

Click here to view a melanoma prognosis calculator of metastatic risk based on primary melanoma depth and location

[back to top]

Graft versus host disease/skin inflammation

  1. Nghiem P. The "Drug vs Graft-vs-Host Disease" Conundrum Gets Tougher but There is an Answer: The Challenge to Dermatologists. Arch Dermatol 2001, 137:75-76. [pdf]

  2. Nghiem P. "Topical Immunomodulators?": Introducing old friends and a new ally, tacrolimus. J Am Acad Dermatol 2001, 44:111-113. [pdf]

  3. Nghiem P, Pearson G, Langley R. Tacrolimus and Pimecrolimus: From Clever Microbes to Inhibiting Calcineurin and Treating Atopic Dermatitis. J Am Acad Dermatol. 2002, 46:228-41. [pdf]

  4. Marra DE, McKee PH, Nghiem P. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease. J Am Acad Dermatol. 2004. 51(4):543-6. [pdf]
  1. Firoz BF, Lee SJ, Nghiem P, Qureshi AA. Role of skin biopsy to confirm suspected accute graft-vs-host disease: results of decision analysis. Arch Deramatol. 2006. 142(2):175-82. [pdf]
 

[back to top]